Changes of TLQP-21 in Response to Glucose Load
AbstractThe TLQP-21 peptide peripherally potentiates glucose-stimulated insulin secretion. The aim of this study was to investigate a possible endocrine mechanism through which TLQP-21 increases the insulin secretion. Using an antibody specific for the common N-terminal portion of the TLQP peptides, we studied pancreas and plasma of mice subjected to intraperitoneal glucose load, by immunohistochemistry and immunosorbent assay (ELISA), alone or coupled to High Performance Liquid Chromatography (HLPC). Mice underwent a period of starvation hence have received a glucose load, or saline, and were sacrificed 30 or 120 minutes later. In normal endocrine pancreas, the TLQP-antiserum stained either peripheral or central cells. Interestingly, 30 min after a glucose load, TLQP immunostaining was disappeared in pancreas and, when analysed by ELISA, the TLQP-levels started to increase in plasma reaching peak concentration at 120 min. (controls vs. 30 and 120 min.: p<0.05 and p<0.001, respectively). The analysis of plasma and pancreas extracts using HLPC coupled to ELISA demonstrated the presence of the TLQP-21, with statistically significant increase of this peptide in plasma at 120 min (vs. controls p<0.05) in agreement to the changes seen by measuring the totality of the TLQP peptides. In pancreas sections we found the presence of the C3a-R1, involved in insulin secretion, and previously identified as a TLQP-21 receptor. Hence, after a glucose load, TLQP-21, may be released by the pancreas into the plasma, returning to the pancreas in order to modulate the insulin secretion through the C3a-R1.